Rubin Marc Insider Trades

Insider Trading History

Track insider trading activity for Rubin Marc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Curis
Curis CRIS
Director
Holding Value $0 0 shares
Last Trade
Mar 20, 2026 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$15.4 20 shares
$0.77
$0.50
Curis
Curis CRIS
Director
Holding Value $14.1k 28,108 shares
Last Trade
Mar 20, 2026 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$20.6k 26,667 shares
$0.77
$0.50
Curis
Curis CRIS
Director
Holding Value $13.3k 26,667 shares
Last Trade
Mar 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.8k 80,021 shares
$0.91
$0.50
Curis
Curis CRIS
Director
Holding Value $7.2k 14,400 shares
Last Trade
May 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.5k 14,400 shares
$2.12
$0.50
Curis
Curis CRIS
Director
Holding Value $800 1,600 shares
Last Trade
Jan 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.01k 1,600 shares
$3.13
$0.50
Galectin Therapeutics
Galectin Therapeutics GALT
Director
Holding Value $143k 60,000 shares
Last Trade
Jan 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.8k 60,000 shares
$1.23
$2.38
Curis
Curis CRIS
Director
Holding Value $2.13k 4,250 shares
Last Trade
May 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49.4k 4,250 shares
$11.62
$0.50
Galectin Therapeutics
Galectin Therapeutics GALT
Director
Holding Value $119k 50,000 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86k 50,000 shares
$1.72
$2.38
Galectin Therapeutics
Galectin Therapeutics GALT
Director
Holding Value $95.2k 40,000 shares
Last Trade
Jan 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.4k 40,000 shares
$1.11
$2.38
Curis
Curis CRIS
Director
Holding Value $42.5k 85,000 shares
Last Trade
Jan 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.8k 85,000 shares
$0.75
$0.50
Curis
Curis CRIS
Director
Holding Value $42.5k 85,000 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$271k 85,000 shares
$3.19
$0.50
Galectin Therapeutics
Galectin Therapeutics GALT
Holding Value $95.2k 40,000 shares
Last Trade
Jan 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$79.2k 40,000 shares
$1.98
$2.38
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
Executive Chairman
Holding Value $152k 65,000 shares
Last Trade
Jan 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.42M 65,000 shares
$21.80
$2.34
Galectin Therapeutics
Galectin Therapeutics GALT
Director
Holding Value $167k 70,000 shares
Last Trade
Mar 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$232k 110,000 shares
$2.11
$2.38
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
Executive Chairman
Holding Value $351k 150,000 shares
Last Trade
Feb 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.1M 150,000 shares
$80.40
$2.34
Curis
Curis CRIS
Director
Holding Value $16.5k 33,000 shares
Last Trade
Jan 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$302k 33,000 shares
$9.14
$0.50
Curis
Curis CRIS
Director
Holding Value $90k 180,000 shares
Last Trade
Mar 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$227k 180,000 shares
$1.26
$0.50
Galectin Therapeutics
Galectin Therapeutics GALT
Director
Holding Value $71.4k 30,000 shares
Last Trade
Jan 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.8k 30,000 shares
$2.86
$2.38
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
Executive Chairman
Holding Value $468k 200,000 shares
Last Trade
Apr 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210M 200,000 shares
$1,050.00
$2.34
Galectin Therapeutics
Galectin Therapeutics GALT
Director
Holding Value $78.7k 33,065 shares
Last Trade
Feb 22, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.84k 859 shares
$5.63
$2.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up